
Sign up to save your podcasts
Or


Mitochondria are famously the powerhouse of the cell, but will mitochondrial therapeutics power the next big mainstream medical breakthrough?
Klaus Dugi is CEO of Vandria, a biotech that develops mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases. He joins 'Beyond Biotech' to talk cell mitophagy, biotech agility, and innovation in tackling neurodegenerative disease.
00:42 Introducing Klaus Dugi
02:51 Lessons learned in top pharma
05:10 The gap that Vandria seeks to fill
06:21 Mitochondrial therapeutics
07:45 Mitophagy inducers and how they work
14:53 Comparing approaches to treating neurodegenerative diseases
17:20 Aging, longevity, and healthy life years
25:26 Challenges ahead
27:31 Performance enhancement and resilience
31:15 Towards the mainstream?
34:35 Looking forward for Vandria
36:02 Developments to watch out for in mitochondrial therapeutics
Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!
Stay updated by subscribing to our newsletter
Regeneration Biomedical has developed a new technique to address neurodegenerative diseases like Alzheimer's using stem cell therapy.
Dr. Christopher Duma, has long been an innovator in neurosurgery using a gamma knife radiosurgery to treat glioblastoma. Now with Regeneration Biomedical, Duma is taking on neurodegenerative diseases with a first-in-human clinical trial where a patient's own stem cells are injected directly into their brain.
On the podcast this week, we talk with Duma about his career in neurosurgery, the impetus for launching his biotech, the promise of stem cell therapy, and the challenges innovators face moving new therapies through the clinic.
00:38 Introducing Dr Christopher Duma
02:44 Advances and breakthroughs in neurosurgery
05:33 The vision and impetus for Regeneration Biomedical
10:45 Regeneration Biomedical’s R&D pipeline
14:12 Milestones ahead
14:46 Advancing beyond Alzheimer’s Disease
15:52 Stems cells from fat cells
19:42 Bypassing the blood-brain barrier
22:45 Patient recruitment
24:13 The treatment process
27:10 The state of stem cell research in the US
29:29 The challenge of financing innovative research
32:15 Global stem cell research landscape
33:14 Controversy in stem cell research
34:00 Future horizons for Regeneration Biomedical
37:23 Partnering with top pharma companies
37:48 Advice for researchers and entrepreneurs
Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!
Stay updated by subscribing to our newsletter
From the publisher's feed
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the…